NASDAQ : KMTS
Kestra Medical Technologies, Ltd. — Key statistics
Healthcare · Medical Instruments & Supplies · United States
Last price 30.61 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 1.82B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 1.78B |
| Enterprise Value | 1.65B |
Dates
| Measure | Value |
|---|
| Earnings Date | Dec 10, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 59.56M |
| Shares Outstanding | 59.56M |
| Shares Change (YoY) | +72.64% |
| Shares Change (QoQ) | +0.29% |
| Owned by Insiders (%) | 1.13% |
| Owned by Institutions (%) | 62.22% |
| Float | 33.72M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 16.73 |
| Forward PS | 11.68 |
| PB Ratio | 7.91 |
| P/TBV Ratio | 8.03 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 15.58 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 4.69 |
| Quick Ratio | 4.44 |
| Debt / Equity | 0.34 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -18.98 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -73.74% |
| Return on Assets (ROA) | -29.23% |
| Return on Invested Capital (ROIC) | -34.01% |
| Return on Capital Employed (ROCE) | -47.99% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | $240,916 |
| Profits Per Employee | -$338,314 |
| Employee Count | 443 |
| Asset Turnover | 0.35 |
| Inventory Turnover | 6.91 |
Taxes
| Measure | Value |
|---|
| Income Tax | 311,000 |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | n/a |
| 52-Week Price Change | +9.06% |
| 50-Day Moving Average | 26.75 |
| 200-Day Moving Average | 23.85 |
| Relative Strength Index (RSI) | 58.18 |
| Average Volume (20 Days) | 409,876 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 3.43M |
| Short Previous Month | 3.28M |
| Short % of Shares Out | 5.76% |
| Short % of Float | 10.17% |
| Short Ratio (days to cover) | 8.74 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 106.73M |
| Gross Profit | 57.51M |
| Operating Income | -143.52M |
| Pretax Income | -149.56M |
| Net Income | -149.87M |
| EBITDA | -134.18M |
| EBIT | -143.52M |
| Loss Per Share | -$2.68 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 198.91M |
| Total Debt | 76.45M |
| Net Cash | 122.47M |
| Net Cash Per Share | $2.06 |
| Equity (Book Value) | 222.36M |
| Book Value Per Share | 3.75 |
| Working Capital | 178.00M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -87.72M |
| Capital Expenditures | -35.49M |
| Depreciation & Amortization | 9.35M |
| Net Borrowing | 24.85M |
| Free Cash Flow | -123.21M |
| FCF Per Share | -$2.07 |
Margins
| Measure | Value |
|---|
| Gross Margin | 53.89% |
| Operating Margin | -134.48% |
| Pretax Margin | -140.14% |
| Profit Margin | -140.43% |
| EBITDA Margin | -125.72% |
| EBIT Margin | -134.48% |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -72.64% |
| Shareholder Yield | -72.64% |
| Earnings Yield | -8.98% |
| FCF Yield | -6.90% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $30.75 |
| Price Target Difference | 3.15% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 9 |
| Revenue Growth Forecast (3Y) | 41.87% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 2.87 |
| Piotroski F-Score | 2 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |